ReviewOpen veterinary journal2025
Review in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Animal Venoms Targeting Cellular Mechanisms: Advances and Implications for Drug Discovery and Disease Therapy.Toxins · 2026Review
- In Silico Assessment ofJournal of pharmacopuncture · 2025Article
- Role of tannin, saponin, and cumin in inhibiting deamination during ensiling: A molecular docking and molecular dynamics approach.Open veterinary journal · 2025Article
- Synthesis, characterization, andFrontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aim: This study examines the snake venom protein's capacity Methods: From Research Collaboratory for Structural Bioinformatics (RCSB)-Protein Data Bank, the active protein structure of catalase-peroxidase, RNA polymerase, and snake venom proteins was derived. Using molecular docking software such as PyRx, PyMOL, and Ligplot analyzers the interactions between those proteins and the targeted intracellular proteins were evaluated. Results: Our findings reveal fascinating affinities and interaction patterns between snake venom proteins and MDR-TB intracellular enzymes. Analysis of the effects of these interactions and their capacity to impair catalase-peroxidase and RNA polymerase showed that Conclusion: This study highlights a prospective approach for advancing anti-TB agents by using snake venom proteins to inhibit the growth, replication, and transmission of MDR-TB. This will provide a basis for exploring pharmacophore-based drugs to combat MDR-TB infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.